Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1966 Mar;6(2):145-52.
doi: 10.1016/S0006-3495(66)86646-8.

A model for the action of vinblastine in vivo

A model for the action of vinblastine in vivo

F A Valeriote et al. Biophys J. 1966 Mar.

Abstract

A model for the action of vinblastine (VLB) on cells multiplying exponentially in vivo with a generation time, T(G), has been derived. It is based on the assumption that cells attempting to pass through mitosis in the presence of VLB lose their proliferative capacity and that this lethal effect occurs only when the cells are exposed to a concentration of VLB which is above a critical value, C(k). The model leads to two predictions. First, that the percentage of cells surviving at any time after exposure to a dose, D, of VLB is 100% if D < D(k) and decreases to 0% after a time, T(G), following a dose D >/= D(k).2(T G/T1/2), where D(k) represents the dose of VLB required to produce the concentration C(k), and T(1/2) is the half-life of the VLB in vivo. Second, that the time, T(G), at which the percentage of cells surviving an exposure to VLB, at doses greater than D(k).2(U G/T1/2), decreases to zero should be equal to the generation time of the cells. Both of these predictions were confirmed experimentally which indicates that the model adequately explains the action of VLB in vivo.

PubMed Disclaimer

References

    1. Cancer Res. 1965 Sep;25(8):1232-7 - PubMed
    1. J Natl Cancer Inst. 1965 Nov;35(5):851-6 - PubMed
    1. Cancer Res. 1961 Dec;21:1542-4 - PubMed
    1. Cancer Res. 1963 Sep;23:1390-427 - PubMed
    1. J Natl Cancer Inst. 1964 May;32:1145-59 - PubMed